These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 1991835
1. Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. Van der Ploeg AT, Kroos MA, Willemsen R, Brons NH, Reuser AJ. J Clin Invest; 1991 Feb; 87(2):513-8. PubMed ID: 1991835 [Abstract] [Full Text] [Related]
3. Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy. Matalon R, Surendran S, Campbell GA, Michals-Matalon K, Tyring SK, Grady J, Cheng S, Kaye E. Biochem Biophys Res Commun; 2006 Nov 24; 350(3):783-7. PubMed ID: 17027913 [Abstract] [Full Text] [Related]
4. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle. Pauly DF, Johns DC, Matelis LA, Lawrence JH, Byrne BJ, Kessler PD. Gene Ther; 1998 Apr 24; 5(4):473-80. PubMed ID: 9614571 [Abstract] [Full Text] [Related]
5. Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle. Van der Ploeg AT, Loonen MC, Bolhuis PA, Busch HM, Reuser AJ, Galjaard H. Pediatr Res; 1988 Jul 24; 24(1):90-4. PubMed ID: 2970619 [Abstract] [Full Text] [Related]
7. Multiple muscles in the AMD quail can be "cross-corrected" of pathologic glycogen accumulation after intravenous injection of an [E1-, polymerase-] adenovirus vector encoding human acid-alpha-glucosidase. McVie-Wylie AJ, Ding EY, Lawson T, Serra D, Migone FK, Pressley D, Mizutani M, Kikuchi T, Chen YT, Amalfitano A. J Gene Med; 2003 May 24; 5(5):399-406. PubMed ID: 12731088 [Abstract] [Full Text] [Related]
8. Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients. Reuser AJ, Kroos MA, Ponne NJ, Wolterman RA, Loonen MC, Busch HF, Visser WJ, Bolhuis PA. Exp Cell Res; 1984 Nov 24; 155(1):178-89. PubMed ID: 6237928 [Abstract] [Full Text] [Related]
9. Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model. Xu F, Ding E, Liao SX, Migone F, Dai J, Schneider A, Serra D, Chen YT, Amalfitano A. Gene Ther; 2004 Nov 24; 11(21):1590-8. PubMed ID: 15356673 [Abstract] [Full Text] [Related]
10. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Raben N, Fukuda T, Gilbert AL, de Jong D, Thurberg BL, Mattaliano RJ, Meikle P, Hopwood JJ, Nagashima K, Nagaraju K, Plotz PH. Mol Ther; 2005 Jan 24; 11(1):48-56. PubMed ID: 15585405 [Abstract] [Full Text] [Related]
11. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line. Martiniuk F, Chen A, Donnabella V, Arvanitopoulos E, Slonim AE, Raben N, Plotz P, Rom WN. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):917-23. PubMed ID: 11027569 [Abstract] [Full Text] [Related]
12. Adeno-associated virus-mediated transfer of human acid maltase gene results in a transient reduction of glycogen accumulation in muscle of Japanese quail with acid maltase deficiency. Lin CY, Ho CH, Hsieh YH, Kikuchi T. Gene Ther; 2002 May 05; 9(9):554-63. PubMed ID: 11973631 [Abstract] [Full Text] [Related]
13. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. Zhu Y, Li X, McVie-Wylie A, Jiang C, Thurberg BL, Raben N, Mattaliano RJ, Cheng SH. Biochem J; 2005 Aug 01; 389(Pt 3):619-28. PubMed ID: 15839836 [Abstract] [Full Text] [Related]
14. [Treatment of Pompe's disease with recombinant enzymes]. Van Hove JL. Verh K Acad Geneeskd Belg; 1998 Aug 01; 60(4):347-57. PubMed ID: 9883081 [Abstract] [Full Text] [Related]
15. Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease. Pauly DF, Fraites TJ, Toma C, Bayes HS, Huie ML, Hirschhorn R, Plotz PH, Raben N, Kessler PD, Byrne BJ. Hum Gene Ther; 2001 Mar 20; 12(5):527-38. PubMed ID: 11268285 [Abstract] [Full Text] [Related]
16. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP, Kamphoven JH, van den Hout HJ, Severijnen LA, van Doorn PA, Reuser AJ, van der Ploeg AT. Muscle Nerve; 2003 Jun 20; 27(6):743-51. PubMed ID: 12766987 [Abstract] [Full Text] [Related]
17. Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. Raben N, Jatkar T, Lee A, Lu N, Dwivedi S, Nagaraju K, Plotz PH. Mol Ther; 2002 Nov 20; 6(5):601-8. PubMed ID: 12409258 [Abstract] [Full Text] [Related]
19. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Görlinger K, Wallot M, Richards S, Voit T. Neuromuscul Disord; 2005 Jan 20; 15(1):24-31. PubMed ID: 15639117 [Abstract] [Full Text] [Related]
20. [Effect of noradrenaline and serotonin on glycogen metabolism in rat tissues]. Roze LV, Popova IA. Vopr Med Khim; 1979 Jan 20; 25(1):50-5. PubMed ID: 106542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]